Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Sell
42
CERT Quote, Financials, Valuation and Earnings
Last price:
$13.91
Seasonality move
:
-6.14%
Day range:
$13.66 - $14.39
52-week range:
$8.64 - $17.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.72x
P/B ratio:
2.09x
Volume:
2M
Avg. volume:
2.3M
1-year change:
-17.14%
Market cap:
$2.2B
Revenue:
$385.1M
EPS (TTM):
-$0.08
Analysts' Opinion
-
Consensus RatingCertara has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $15.44, Certara has an estimated upside of 12.49% from its current price of $13.73.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $13.73.
Fair Value
-
According to the consensus of 11 analysts, Certara has 12.49% upside to fair value with a price target of $15.44 per share.
CERT vs. S&P 500
-
Over the past 5 trading days, Certara has underperformed the S&P 500 by -7.74% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Certara does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Certara has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Certara reported revenues of $100.4M.
Earnings Growth
-
Certara has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Certara reported earnings per share of $0.04.
Enterprise value:
2.3B
EV / Invested capital:
--
Price / LTM sales:
5.72x
EV / EBIT:
536.67x
EV / Revenue:
6.04x
PEG ratio (5yr expected):
--
EV / Free cash flow:
39.16x
Price / Operating cash flow:
37.06x
Enterprise value / EBITDA:
32.15x
Gross Profit (TTM):
$230.6M
Return On Assets:
-0.78%
Net Income Margin (TTM):
-3.13%
Return On Equity:
-1.15%
Return On Invested Capital:
-0.9%
Operating Margin:
5.98%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $335.6M | $354.3M | $385.1M | $88M | $100.4M | |
| Gross Profit | $203.1M | $213.3M | $230.6M | $53.9M | $62.1M | |
| Operating Income | $32.5M | $6.2M | -$1.7M | -$8.5M | $6M | |
| EBITDA | $89M | $23.8M | $72.4M | $8.3M | $25.4M | |
| Diluted EPS | $0.09 | -$0.35 | -$0.08 | -$0.08 | $0.04 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $346.6M | $274.7M | $342.3M | $340.2M | $310.9M | |
| Total Assets | $1.3B | $1.5B | $1.6B | $1.6B | $1.6B | |
| Current Liabilities | $75.3M | $92.2M | $103.2M | $130M | $146.1M | |
| Total Liabilities | $447.3M | $469.9M | $493.3M | $516.3M | $516.4M | |
| Total Equity | $822.1M | $1B | $1.1B | $1B | $1.1B | |
| Total Debt | $298.8M | $294.8M | $293M | $291.2M | $295.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $92.5M | $82.8M | $80.5M | $23.3M | $49.4M | |
| Cash From Investing | -$27.8M | -$79.6M | -$112.4M | -$61M | -$97.2M | |
| Cash From Financing | -$7.4M | -$9.4M | -$21M | -$1.3M | -$1.3M | |
| Free Cash Flow | $80M | $67.4M | $59.4M | $19M | $43.5M | |
CERT
Sector
Market Cap
$2.2B
$34.4M
Price % of 52-Week High
76.53%
44.25%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.82%
1-Year Price Total Return
-17.14%
-39.44%
Beta (5-Year)
--
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$14.15
200-day SMA
Buy
Level
$12.05
Bollinger Bands (100)
Buy
Level
10.41 - 13.43
Chaikin Money Flow
Buy
Level
24.3M
20-day SMA
Buy
Level
$12.12
Relative Strength Index (RSI14)
Buy
Level
61.35
ADX Line
Buy
Level
36.84
Williams %R
Neutral
Level
-24.4626
50-day SMA
Buy
Level
$11.91
MACD (12, 26)
Buy
Level
0.90
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
6.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2573)
Buy
CA Score
(Annual)
Level (0.4278)
Buy
Beneish M-Score
(Annual)
Level (-2.5837)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.0391)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Stock Forecast FAQ
In the current month, CERT has received 4 Buy ratings 7 Hold ratings, and 0 Sell ratings. The CERT average analyst price target in the past 3 months is $15.44.
-
Where Will Certara Stock Be In 1 Year?
According to analysts, the consensus estimate is that Certara share price will rise to $15.44 per share over the next 12 months.
-
What Do Analysts Say About Certara?
Analysts are divided on their view about Certara share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Certara is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Certara's Price Target?
The price target for Certara over the next 1-year time period is forecast to be $15.44 according to 11 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is CERT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Certara is a Hold. 7 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CERT?
You can purchase shares of Certara via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Certara shares.
-
What Is The Certara Share Price Today?
Certara was last trading at $13.91 per share. This represents the most recent stock quote for Certara. Yesterday, Certara closed at $13.73 per share.
-
How To Buy Certara Stock Online?
In order to purchase Certara stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
39
RGC alert for Apr 29
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
76
EXOD alert for Apr 29
Exodus Movement [EXOD] is down 3.2% over the past day.
Sell
48
SBGSY alert for Apr 29
Schneider Electric SE [SBGSY] is down 0.17% over the past day.
